Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23 USD | -3.69% | +2.22% | -24.57% |
04-15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
03-25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |